Sanofi-Aventis is facing another lawsuit over its chemotherapy drug Taxotere (generic: docetaxel), the latest filed by a Louisiana woman who claims she suffered permanent hair loss, or alopecia, after being treated with the medication.
Free Confidential Lawsuit Evaluation: If you experienced permanent hair loss or “alopecia” after chemotherapy with Taxotere, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What’s the Problem?
November 21, 2016 – In a complaint (PDF) filed Oct. 18 in the U.S. District Court for the District of Louisiana, Plaintiff Iris Guidry alleges that Sanofi-Aventis failed to warn consumers about the risk of permanent hair loss with Taxotere.
While hair loss is a common side effect of chemotherapy, it is usually temporary and Sanofi has claimed that hair usually grows back following treatment with the drug. However, Guidry alleges that since she had chemo for breast cancer with Taxotere in 2011, she has continued to experience hair loss side effects.
Taxotere was approved by the U.S. Food & Drug Administration (FDA) in 1996, and marketed by Sanofi as superior to earlier low-potency taxanes, such as Taxol (generic: paclitaxel). However, lawsuits allege that Taxotere is no more effective at treating breast cancer, yet carries a risk of permanent hair loss, or alopecia, which has not been associated with other chemotherapy treatments.
While Taxotere labels in other countries warned about the risk of permanent hair loss, that same information was not provided to doctors and patients in the U.S., according to the lawsuits.
“Defendants have chosen to withhold this information in the United States despite advising physicians, patients, and regulatory agencies in other countries, including the European Union and Canada, that Taxotere causes an increased risk of permanent disfiguring hair loss,” Guidry’s complaint states. “Defendants instead continued to warn or advise physicians, healthcare providers, patients, and Plaintiff in the United States only with the generic, vague, and insufficient warning that ‘hair generally grows back’ after taking Taxotere.”
Last month, a panel of judges centralized all federal lawsuits alleging permanent hair loss from Taxotere into a multidistrict litigation (MDL No. 2740) in the Eastern District of Louisiana before Judge Lance M. Africk. Only about 35 complaints are currently pending in the MDL, but is estimated that this number will grow into the hundreds or even thousands by the time the litigation process is complete.
Do I Have a Taxotere Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Taxotere lawsuits. We are handling individual litigation nationwide and currently accepting new hair loss and balding cases in all 50 states.
Free Case Evaluation: Again, if you lost hair and were unable to grow it back after undergoing chemo with Taxotere, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.